TWO SIGMA INVESTMENTS, LP

Position in CORT — Corcept Therapeutics Inc

CIK 1179392 NEW YORK, NY

Position in CORT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$53,046,282

+$14,917,698 QoQ

Shares Held

610,078

-35.5% QoQ

Ownership

0.564%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#25

of 423 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 99% Shared 0% None 1%

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $7,273,657,992 across 342 Biotechnology names. CORT ranks #35 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,875,937	$564,713,315
2	MRNA	Moderna, Inc.	7,193,530	$503,762,905
3	IONS	Ionis Pharmaceuticals Inc	6,252,342	$495,748,197
4	REGN	Regeneron Pharmaceuticals, Inc.	656,124	$409,119,558
5	BBIO	BridgeBio Pharma, Inc.	4,722,185	$351,708,338
6	EXEL	Exelixis, Inc.	4,209,861	$229,058,537
7	INCY	Incyte Corp	2,003,559	$227,123,448
8	ARGX	Argenx SE	185,638	$172,229,367

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$53,046,282	610,078	-35.5%	Shares	Sole	2026-08-14
2026-03-31	$38,128,584	945,884	+3283.1%	Shares	Sole	2026-05-15
2025-12-31	$972,973	27,959	-33.6%	Shares	Sole	2026-02-17
2025-09-30	$3,501,091	42,126	-30.8%	Shares	Sole	2025-11-14
2025-06-30	$4,465,949	60,844	-66.2%	Shares	Sole	2025-08-14
2025-03-31	$20,576,618	180,149	-11.0%	Shares	Sole	2025-05-15
2024-12-31	$10,205,385	202,528	-43.1%	Shares	Sole	2025-02-14
2024-09-30	$16,477,994	356,050	-9.6%	Shares	Sole	2024-11-14
2024-06-30	$12,793,912	393,780	-51.9%	Shares	Sole	2024-08-14
2024-03-31	$20,617,385	818,475	+71.4%	Shares	Sole	2024-05-15
2023-12-31	$15,511,051	477,557	+87.1%	Shares	Sole	2024-02-14
2023-09-30	$6,955,971	255,265	+46.2%	Shares	Sole	2023-11-14
2023-06-30	$3,883,604	174,544	+1553.8%	Shares	Sole	2023-08-14
2020-03-31	$125,487	10,554	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.